Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
clinical cure | resolution of infection-related signs and symptoms under a stated definition | Clinical cure was assessed at the scheduled follow-up visit. | Assessment | Infection course, epidemiology and source attribution |
microbiologic eradication | organism is no longer detected by the specified follow-up testing | Microbiologic eradication was documented with the specimen and timing of collection. | Assessment | Infection course, epidemiology and source attribution |
microbiologic persistence | organism remains detectable on relevant repeat testing | Microbiologic persistence was interpreted in light of whether the assay reflects viable organisms. | Assessment | Infection course, epidemiology and source attribution |
residual inflammatory change | inflammatory findings remain after improvement in the underlying process | The residual inflammatory change was considered when imaging lagged behind clinical recovery. | Assessment | Infection course, epidemiology and source attribution |
septic embolization | infected material travels through blood to a distant site | Septic embolization was included in the differential for the peripheral lesions. | Assessment | Infection course, epidemiology and source attribution |
suppurative complication | localized pus formation or another complication of purulent inflammation | The suppurative complication was considered after focal swelling developed. | Assessment | Infection course, epidemiology and source attribution |
culture-negative infection | infection remains a clinical consideration despite negative cultures | Culture-negative infection was assessed with prior antimicrobial exposure documented. | Assessment | Infection course, epidemiology and source attribution |
antibiotic pretreatment | antimicrobials received before obtaining the diagnostic sample | Antibiotic pretreatment was considered when interpreting negative cultures. | Assessment | Infection course, epidemiology and source attribution |
inoculum effect | observed antimicrobial activity changes with the starting number of organisms tested | Inoculum effect was discussed with microbiology in relation to the assay. | Assessment | Infection course, epidemiology and source attribution |
host susceptibility | patient factors increase vulnerability to a specific infection | Host susceptibility was assessed from immune status, devices and prior exposures. | Assessment | Infection course, epidemiology and source attribution |
clinical stage | extent of cancer estimated from evaluation before definitive pathology | Clinical stage was recorded with its basis and date. | Assessment | Cancer, treatment response and transplant assessment |
pathologic stage | extent of disease determined using the required pathologic evidence | Pathologic stage was documented using the resection and nodal findings. | Assessment | Cancer, treatment response and transplant assessment |
restaging | reassessment of disease extent after a change in time or treatment | Restaging was based on the current imaging and biopsy report. | Assessment | Cancer, treatment response and transplant assessment |
localized disease | disease confined to its site of origin under the stated classification | Localized disease was the assessment after review of the staging workup. | Assessment | Cancer, treatment response and transplant assessment |
locoregional disease | disease involving the primary area or its regional tissues or nodes | Locoregional disease was distinguished in the note from distant sites under evaluation. | Assessment | Cancer, treatment response and transplant assessment |
distant metastasis | tumor spread to a nonregional site | Distant metastasis was confirmed on biopsy of the separate lesion. | Assessment | Cancer, treatment response and transplant assessment |
nodal involvement | disease identified in lymph nodes | Nodal involvement was documented with the number and location of involved nodes. | Assessment | Cancer, treatment response and transplant assessment |
occult primary | site of origin remains unidentified after the stated evaluation | Occult primary was discussed after malignancy was confirmed in a node. | Assessment | Cancer, treatment response and transplant assessment |
synchronous primary tumors | distinct primary tumors diagnosed in the same clinical period | Synchronous primary tumors were reviewed separately at the case conference. | Assessment | Cancer, treatment response and transplant assessment |
metachronous primary tumor | separate primary cancer diagnosed at a later time | Metachronous primary tumor was considered after comparison with the earlier pathology. | Assessment | Cancer, treatment response and transplant assessment |
local recurrence | return of disease at or near the treated primary site | Local recurrence was assessed by comparison with the treatment field. | Assessment | Cancer, treatment response and transplant assessment |
regional recurrence | disease returning in the regional nodes or nearby tissues | Regional recurrence was documented with the nodal basin specified. | Assessment | Cancer, treatment response and transplant assessment |
distant recurrence | return of disease at a site away from the original or regional area | Distant recurrence was assessed on the new staging examination. | Assessment | Cancer, treatment response and transplant assessment |
measurable disease | disease meeting specified criteria for reproducible measurement | Measurable disease was identified using the criteria named in the report. | Assessment | Cancer, treatment response and transplant assessment |
target lesion | lesion selected for serial measurement under stated response criteria | Target lesion was measured on the same imaging series used for follow-up. | Assessment | Cancer, treatment response and transplant assessment |